Related Experiment Videos
New horizons in neuroprotection.
1Scheie Eye Institute and Department of Ophthalmology, the University of Pennsylvania, Philadelphia, PA 19104, USA.
Survey of Ophthalmology
|May 30, 2001
Summary
Glaucoma, a major cause of blindness, involves elevated intraocular pressure and retinal ganglion cell death. This article reviews recent discoveries in its pathophysiology, including nitric oxide and glutamate roles.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Glaucoma is a leading cause of worldwide blindness and irreversible blindness in the USA.
- Primary open angle glaucoma, the most common form, features chronically elevated intraocular pressure without apparent structural eye abnormalities.
- Glaucomatous optic neuropathy is characterized by selective retinal ganglion cell death and optic nerve head structural changes.
Purpose of the Study:
- To review recent scientific discoveries concerning the pathophysiology of glaucomatous optic neuropathy.
- To highlight the roles of specific molecular and cellular processes in glaucoma development.
Main Methods:
- Literature review of recent research on glaucoma pathophysiology.
- Synthesis of findings related to nitric oxide, glutamate, and apoptosis in glaucoma.
Main Results:
- Recent discoveries implicate nitric oxide, glutamate, and apoptosis in the mechanisms underlying glaucomatous optic neuropathy.
- These factors contribute to the selective death of retinal ganglion cells.
Conclusions:
- Emerging research provides new insights into the complex pathophysiology of glaucoma.
- Understanding these mechanisms is crucial for developing future therapeutic strategies for vision preservation.